Cargando…

C-type lectins in HIV-1 infection

Detalles Bibliográficos
Autor principal:	Geijtenbeek, Teunis BH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236872/ http://dx.doi.org/10.1186/1742-4690-8-S2-O27

Ejemplares similares

Signalling through C-type lectin receptors: shaping immune responses
por: Geijtenbeek, Teunis B. H., et al.
Publicado: (2009)

C-type lectin Langerin is a β-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi
por: de Jong, Marein A.W.P., et al.
Publicado: (2010)

C-Type Lectin Receptors in Antiviral Immunity and Viral Escape
por: Bermejo-Jambrina, Marta, et al.
Publicado: (2018)

High resolution lectin microarray system for the ATL cell-typing and the evaluation of anti-cancer efficacy of medications
por: Iha, Hidekatsu, et al.
Publicado: (2014)

Immunodynamics of Th17 cells in HIV-1 subtype ‘C’ infection
por: Vajpayee, Madhu, et al.
Publicado: (2012)

Variant cell types and host glycoproteins influencing HIV-1 infection
por: Paxton, William A
Publicado: (2011)

O052: Use of surgical-site infection rates to rank hospital performance across several types of surgery
por: van Dishoeck, AM, et al.
Publicado: (2013)

Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
por: Cevik, Muge, et al.
Publicado: (2012)

Various Tastes of Sugar: The Potential of Glycosylation in Targeting and Modulating Human Immunity via C-Type Lectin Receptors
por: Busold, Stefanie, et al.
Publicado: (2020)

Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men
por: Nijmeijer, Bernadien M, et al.
Publicado: (2019)

Transcriptional modulation of HIV-1C LTR promoter
por: Singh, Anand, et al.
Publicado: (2012)

Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from subtype-C HIV-1 infected north Indians; implications for MPER directed HIV-1 neutralization
por: Andrabi, Raiees, et al.
Publicado: (2012)

Genetic variation in HIV-1C: implications for prevention and treatment
por: Essex, Max
Publicado: (2006)

Beneficial HLA-mediated viral polymorphisms on the transmitted virus additively influence disease progression in HIV-1, subtype C infection
por: Ntale, RS, et al.
Publicado: (2012)

The C5 region of HIV-1 gp120 binds specific
por: Dalgleish, A, et al.
Publicado: (2006)

Abortive HIV‐1 RNA induces pro‐IL‐1β maturation via protein kinase PKR and inflammasome activation in humans
por: Stunnenberg, Melissa, et al.
Publicado: (2021)

Low prevalence of hepatitis C infection among HIV-infected individuals in Slovenia: a nationwide study, 1985–2013
por: Seme, Katja, et al.
Publicado: (2014)

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
por: Huik, Kristi, et al.
Publicado: (2014)

The enhancement of HIV-1 infectivity by Nef depends on dynamin 2
por: Pizzato, Massimo, et al.
Publicado: (2006)

Efficient macrophage infection by phagocytosis of dying HIV-1 -infected CD4+T cells
por: Groot, Fedde, et al.
Publicado: (2011)

Attacking latent HIV: towards eradication of HIV infection
por: Margolis, DM
Publicado: (2006)

HIV-1 subtype C viruses rapidly develop K65R
por: Wainberg, Mark A, et al.
Publicado: (2006)

DC SIGNR silencing reduces HIV-1 infection in Dendritic cells
por: Chaudhary, Omkar, et al.
Publicado: (2014)

HIV-1 infection and circulating peripheral blood B cell subpopulations
por: Singh, Ravinder, et al.
Publicado: (2014)

Innate immune responses in acute HIV-1 infection: protective or pathogenic?
por: Borrow, Persephone, et al.
Publicado: (2013)

Cardiovascular impairment in young adults horizontally infected with HIV-1 in childhood
por: Dumitrescu, Florentina, et al.
Publicado: (2013)

NK-dependent survival of HIV-1 infected DCs. Pivotal role of HMGB1
por: Melki, Marie-Thérèse, et al.
Publicado: (2010)

OA011-01. Early events of human immunodeficiency virus type 1 (HIV-1) ex vivo penetration in the foreskin mimicking HIV-1 sexual transmission
por: Ganor, Y, et al.
Publicado: (2009)

A first-in-man, double blind, placebo controlled study of the candidate therapeutic vaccine Opal-HIV-Gag(c) in HIV infected patients receiving HAART
por: Jackson, AG, et al.
Publicado: (2012)

Influence of liver fibrosis stage on nevirapine plasma concentration in HIV-infected patients with chronic hepatitis C virus
por: Dragovic, Gordana, et al.
Publicado: (2014)

Approaches to eradication of latent HIV infection
por: Margolis, David
Publicado: (2013)

HLA-A*0201-specific epitopes of Indian HIV-1C as candidates for vaccine design
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2012)

Crosstalk between R848 and abortive HIV‐1 RNA‐induced signaling enhances antiviral immunity
por: Stunnenberg, Melissa, et al.
Publicado: (2022)

Concordance between noninvasive assessments of fibrosis in patients with HIV/HIV+HBV infection
por: Dumea, Elena, et al.
Publicado: (2014)

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia
por: Garrido, C, et al.
Publicado: (2010)

Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort
por: Baumgarten, A, et al.
Publicado: (2010)

CD4-Induced epitopes in HIV infection
por: DeVico, Anthony, et al.
Publicado: (2006)

Elite control of HIV infection: implications for vaccines
por: Pereyra, Florencia, et al.
Publicado: (2006)

Muco-cutaneous manifestations in HIV infection/AIDS
por: Benea, Vasile, et al.
Publicado: (2014)

Th1/Th17 gammadelta T cells are expanded in HIV-1 infected patients and respond to Candida albicans
por: Poggi, Alessandro, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nj1861c1tj7bj21h9stlnrjbrt